The University of Chicago Header Logo

Matthew Baggott

InstitutionUniversity of Chicago
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Johnson CB, Walther D, Baggott MJ, Baker LE, Baumann MH. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. J Pharmacol Exp Ther. 2024 Jan 25. PMID: 38272669.
      Citations:    Fields:    
    2. Agurto C, Cecchi GA, Norel R, Ostrand R, Kirkpatrick M, Baggott MJ, Wardle MC, Wit H, Bedi G. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology. 2020 04; 45(5):823-832. PMID: 31978933; PMCID: PMC7075895.
      Citations: 10     Fields:    Translation:Humans
    3. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):108-117. PMID: 30967099.
      Citations: 7     Fields:    Translation:Humans
    4. Bershad AK, Miller MA, Baggott MJ, de Wit H. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? J Psychopharmacol. 2016 12; 30(12):1248-1258. PMID: 27562198; PMCID: PMC8753974.
      Citations: 40     Fields:    Translation:Humans
    5. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. MDMA Impairs Response to Water Intake in Healthy Volunteers. Adv Pharmacol Sci. 2016; 2016:2175896. PMID: 27403159; PMCID: PMC4923534.
      Citations: 2     
    6. Baggott MJ, Coyle JR, Siegrist JD, Garrison KJ, Galloway GP, Mendelson JE. Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. J Psychopharmacol. 2016 Apr; 30(4):378-87. PMID: 26880224.
      Citations: 21     Fields:    Translation:Humans
    7. Baggott MJ, Kirkpatrick MG, Bedi G, de Wit H. Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. PMID: 25922420; PMCID: PMC4698152.
      Citations: 23     Fields:    Translation:Humans
    8. Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, de Wit H, Hysek CM. MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. PMID: 24633447; PMCID: PMC4161650.
      Citations: 26     Fields:    Translation:Humans
    9. Weafer J, Baggott MJ, de Wit H. Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Exp Clin Psychopharmacol. 2013 Dec; 21(6):475-81. PMID: 24099351; PMCID: PMC4266373.
      Citations: 78     Fields:    Translation:HumansCTClinical Trials
    10. Pal R, Balt S, Erowid E, Erowid F, Baggott MJ, Mendelson J, Galloway GP. Ketamine is associated with lower urinary tract signs and symptoms. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):189-94. PMID: 23474358.
      Citations: 7     Fields:    Translation:Humans
    11. Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013 Jul; 228(1):109-18. PMID: 23420115; PMCID: PMC3672386.
      Citations: 26     Fields:    Translation:Humans
    12. Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther. 2011 Jul; 90(1):179-83. PMID: 21633343.
      Citations: 15     Fields:    Translation:Humans
    13. Li L, Galloway GP, Verotta D, Everhart ET, Baggott MJ, Coyle JR, Lopez JC, Mendelson J. A method to quantify illicit intake of drugs from urine: methamphetamine. J Pharmacol Exp Ther. 2011 Jul; 338(1):31-6. PMID: 21450932; PMCID: PMC3126645.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Mendelson J, Baggott MJ, Flower K, Galloway G. Developing biomarkers for methamphetamine addiction. Curr Neuropharmacol. 2011 Mar; 9(1):100-3. PMID: 21886571; PMCID: PMC3137160.
      Citations: 5     Fields:    
    15. Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CY, Mendelson J. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther. 2011 Feb; 89(2):276-82. PMID: 21178989; PMCID: PMC3514554.
      Citations: 35     Fields:    Translation:Humans
    16. Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology (Berl). 2011 Apr; 214(4):933-9. PMID: 21140258; PMCID: PMC3063546.
      Citations: 11     Fields:    Translation:HumansAnimals
    17. Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. PLoS One. 2010 Dec 02; 5(12):e14074. PMID: 21152030; PMCID: PMC2996283.
      Citations: 6     Fields:    Translation:HumansCells
    18. Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC. Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend. 2011 Mar 01; 114(1):61-7. PMID: 21035275.
      Citations: 15     Fields:    Translation:Humans
    19. Garrison KJ, Coyle JR, Baggott MJ, Mendelson J, Galloway GP. Imagery scripts and a computerized subtraction stress task both induce stress in methamphetamine users: a controlled laboratory study. Subst Abuse. 2010; 4:53-60. PMID: 22879743; PMCID: PMC3411501.
    20. Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend. 2010 Oct 01; 111(3):250-6. PMID: 20627425.
      Citations: 27     Fields:    Translation:HumansAnimals
    21. Flower K, Li L, Chen CY, Baggott MJ, Galloway GP, Mendelson J. Efficacy, safety, and ethics of cosmetic neurology far from settled. Clin Pharmacol Ther. 2010 Oct; 88(4):461-3. PMID: 20856245.
      Citations:    Fields:    Translation:Humans
    22. Galloway GP, Singleton EG, Buscemi R, Baggott MJ, Mendelson JE, Methamphetamine Treatment Project Corporate Authors, Dickerhoof RM. An examination of drug craving over time in abstinent methamphetamine users. Am J Addict. 2010 Nov-Dec; 19(6):510-4. PMID: 20958846.
      Citations: 17     Fields:    Translation:Humans
    23. Li L, Lopez JC, Galloway GP, Baggott MJ, Everhart T, Mendelson J. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. Ther Drug Monit. 2010 Aug; 32(4):504-7. PMID: 20592647; PMCID: PMC3040572.
      Citations: 6     Fields:    Translation:Humans
    24. Connelly WM, Baggott MJ. Role of endocannabinoids in 5-HT2 receptor-mediated effects. J Neurophysiol. 2009 Jan; 101(1):5-7. PMID: 19004992.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    25. Dufka F, Galloway G, Baggott M, Mendelson J. The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial. Br J Sports Med. 2009 Oct; 43(11):832-5. PMID: 18981044.
      Citations: 8     Fields:    Translation:Humans
    26. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2002 Aug; 162(4):396-405. PMID: 12172693.
      Citations: 74     Fields:    Translation:HumansCTClinical Trials
    27. Baggott MJ. Preventing problems in Ecstasy users: reduce use to reduce harm. J Psychoactive Drugs. 2002 Apr-Jun; 34(2):145-62. PMID: 12691205.
      Citations: 6     Fields:    Translation:HumansAnimals
    28. Vollenweider FX, Jones RT, Baggott MJ. Caveat emptor: editors beware. Neuropsychopharmacology. 2001 Apr; 24(4):461-3. PMID: 11310414.
      Citations: 6     Fields:    Translation:HumansAnimals
    29. Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med. 2000 Dec 19; 133(12):969-73. PMID: 11119398.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    30. Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. JAMA. 2000 Nov 01; 284(17):2190. PMID: 11056589.
      Citations: 27     Fields:    Translation:Humans
    31. Baggott M, Mendelson J, Jones R. More about parkinsonism after taking ecstasy. N Engl J Med. 1999 Oct 28; 341(18):1400-1. PMID: 10577097.
      Citations: 2     Fields:    Translation:Humans
    32. Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology (Berl). 1999 Jan; 141(1):37-46. PMID: 9952063.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    33. Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clin Pharmacol Ther. 1996 Jul; 60(1):105-14. PMID: 8689806.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    34. Richards JB, Baggott MJ, Sabol KE, Seiden LS. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Res. 1993 Nov 12; 627(2):254-60. PMID: 8298969.
      Citations: 6     Fields:    Translation:Animals
    Baggott's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (155)
    Co-Authors (4)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors